• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-生育酚对阿霉素心脏毒性影响的临床与药理学研究。

Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity.

作者信息

Legha S S, Wang Y M, Mackay B, Ewer M, Hortobagyi G N, Benjamin R S, Ali M K

出版信息

Ann N Y Acad Sci. 1982;393:411-8. doi: 10.1111/j.1749-6632.1982.tb31279.x.

DOI:10.1111/j.1749-6632.1982.tb31279.x
PMID:6959564
Abstract

Our data indicate that alpha-tocopherol used in an oral dose of 2 g/m2 daily results in a six- to eightfold increase of the vitamin E levels in serum. The occurrence of congestive heart failure in three patients and the observation of significant pathologic changes in endomyocardial biopsies in approximately half of the patients treated with a median cumulative adriamycin dose level of 550 mg/m2 indicate that alpha-tocopherol does not offer substantial protection against adriamycin-induced cardiac toxicity. The antitumor activity of the drug, however, is not compromised by the concomitant administration of the vitamin.

摘要

我们的数据表明,每日口服剂量为2 g/m²的α-生育酚会使血清中维生素E水平提高6至8倍。3名患者出现充血性心力衰竭,并且在接受中位累积阿霉素剂量水平为550 mg/m²治疗的患者中,约有一半的患者心内膜活检观察到明显的病理变化,这表明α-生育酚并不能有效预防阿霉素引起的心脏毒性。然而,该药物的抗肿瘤活性并未因同时服用维生素而受到影响。

相似文献

1
Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity.α-生育酚对阿霉素心脏毒性影响的临床与药理学研究。
Ann N Y Acad Sci. 1982;393:411-8. doi: 10.1111/j.1749-6632.1982.tb31279.x.
2
Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.吡柔比星联合5-氟尿嘧啶和环磷酰胺治疗转移性乳腺癌的II期临床与药理学研究
Clin Cancer Res. 1995 Jul;1(7):691-7.
3
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion.通过延长持续静脉输注降低阿霉素的心脏毒性。
Ann Intern Med. 1982 Feb;96(2):133-9. doi: 10.7326/0003-4819-96-2-133.
4
High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.大剂量输注阿霉素和环磷酰胺:无干细胞支持的串联大剂量化疗周期可行性研究。
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2337-45.
5
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial.氟尿嘧啶、表柔比星和环磷酰胺对比氟尿嘧啶、多柔比星和环磷酰胺用于晚期乳腺癌的III期随机研究:一项意大利多中心试验
J Clin Oncol. 1988 Jun;6(6):976-82. doi: 10.1200/JCO.1988.6.6.976.
6
Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer.双哌嗪二酮ICRF-187对晚期乳腺癌女性患者阿霉素诱导的心脏毒性的保护作用。
N Engl J Med. 1988 Sep 22;319(12):745-52. doi: 10.1056/NEJM198809223191203.
7
A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamide.一项在接受5-氟尿嘧啶、多柔比星和环磷酰胺治疗的晚期乳腺癌患者中使用Cardioxane(ICRF-187)进行心脏保护的II期试验。
Oncology. 1995 May-Jun;52(3):251-5. doi: 10.1159/000227467.
8
Adriamycin cardiotoxicity amelioration by alpha-tocopherol.
Am J Pediatr Hematol Oncol. 1979 Summer;1(2):151-3.
9
Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.阿霉素对耐环磷酰胺、甲氨蝶呤、5-氟尿嘧啶、长春新碱和泼尼松联合方案的转移性乳腺癌的活性。
Cancer Treat Rep. 1978 Mar;62(3):449-50.
10
Failure of high-dose tocopherol to prevent alopecia induced by doxorubicin.
N Engl J Med. 1986 Oct 2;315(14):894-5. doi: 10.1056/NEJM198610023151416.

引用本文的文献

1
Cell-Permeable Microprotein from Panax Ginseng Protects Against Doxorubicin-Induced Oxidative Stress and Cardiotoxicity.人参来源的细胞穿透性微小蛋白可抵御阿霉素诱导的氧化应激和心脏毒性。
Antioxidants (Basel). 2025 Apr 19;14(4):493. doi: 10.3390/antiox14040493.
2
PCSK9 Inhibitors and Anthracyclines: The Future of Cardioprotection in Cardio-Oncology.前蛋白转化酶枯草溶菌素9抑制剂与蒽环类药物:心脏肿瘤学中心脏保护的未来。
Hearts (Basel). 2024 Sep;5(3):375-388. doi: 10.3390/hearts5030027. Epub 2024 Sep 3.
3
Role of mitochondria in doxorubicin-mediated cardiotoxicity: from molecular mechanisms to therapeutic strategies.
线粒体在阿霉素介导的心脏毒性中的作用:从分子机制到治疗策略
Int J Med Sci. 2024 Mar 11;21(5):809-816. doi: 10.7150/ijms.94485. eCollection 2024.
4
Mito-TEMPO mitigates 5-fluorouracil-induced intestinal injury via attenuating mitochondrial oxidative stress, inflammation, and apoptosis: an in vivo study.Mito-TEMPO 通过减轻线粒体氧化应激、炎症和细胞凋亡缓解 5-氟尿嘧啶诱导的肠道损伤:一项体内研究。
Inflammopharmacology. 2023 Aug;31(4):2091-2102. doi: 10.1007/s10787-023-01261-6. Epub 2023 Jun 20.
5
Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity.线粒体靶向治疗多柔比星所致心脏毒性。
Int J Mol Sci. 2022 Feb 9;23(3):1912. doi: 10.3390/ijms23031912.
6
Natural Products Counteracting Cardiotoxicity during Cancer Chemotherapy: The Special Case of Doxorubicin, a Comprehensive Review.天然产物对抗癌症化疗中心脏毒性:多柔比星的特殊情况,全面综述。
Int J Mol Sci. 2021 Sep 17;22(18):10037. doi: 10.3390/ijms221810037.
7
Doxyl Nitroxide Spin Probes Can Modify Toxicity of Doxorubicin towards Fibroblast Cells. doxyl 硝氧自由基探针可修饰阿霉素对成纤维细胞的毒性。
Molecules. 2020 Nov 4;25(21):5138. doi: 10.3390/molecules25215138.
8
New insights into the activities and toxicities of the old anticancer drug doxorubicin.对老抗癌药物阿霉素的活性和毒性的新认识。
FEBS J. 2021 Nov;288(21):6095-6111. doi: 10.1111/febs.15583. Epub 2020 Oct 19.
9
Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?蒽环类药物所致心脏毒性的机制:线粒体功能障碍是答案吗?
Front Cardiovasc Med. 2020 Mar 12;7:35. doi: 10.3389/fcvm.2020.00035. eCollection 2020.
10
Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity - Exploring the armoury of obscurity.抗氧化剂作为对抗癌症化疗诱导毒性的精准武器——探索未知的宝库。
Saudi Pharm J. 2018 Feb;26(2):177-190. doi: 10.1016/j.jsps.2017.12.013. Epub 2017 Dec 19.